Portuguese reforms address “increasingly complex” medtech
This article was originally published in Clinica
Portugal is in the early stages of a root-and-branch review of the structure, operation and management of national health system (SNS) hospitals. This will likely have implications for the purchasing, distribution and handling of medical supplies. Next week sees the conclusion of a public consultation on the priorities for modernisation and quality improvement.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.